Shaanxi Meibang Pharmaceutical Group Co., Ltd. Stock

Equities

605033

CNE100005071

Agricultural Chemicals

End-of-day quote Shanghai S.E. 18:00:00 2024-06-06 EDT 5-day change 1st Jan Change
12.93 CNY +4.78% Intraday chart for Shaanxi Meibang Pharmaceutical Group Co., Ltd. -12.16% -27.97%

Financials

Sales 2022 906M 125M 172M Sales 2023 699M 96.46M 133M Capitalization 2.43B 335M 461M
Net income 2022 145M 20.01M 27.54M Net income 2023 57M 7.87M 10.82M EV / Sales 2022 2.16 x
Net cash position 2022 398M 54.94M 75.61M Net cash position 2023 481M 66.31M 91.25M EV / Sales 2023 2.78 x
P/E ratio 2022
16 x
P/E ratio 2023
41.7 x
Employees 939
Yield 2022
1.29%
Yield 2023
0.84%
Free-Float 18.89%
More Fundamentals * Assessed data
Dynamic Chart
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Meibang Pharmaceutical Earmarks 1.4 Billion Yuan for Factory Construction MT
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shaanxi Yatai Testing and Evaluation Co., Ltd. announced that it has received CNY 25 million in funding from Shaanxi Meibang Pharmaceutical Group Co., Ltd. CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shaanxi Yatai Testing and Evaluation Co., Ltd. announced that it expects to receive CNY 25 million in funding from Shaanxi Meibang Pharmaceutical Group Co., Ltd. CI
Shaanxi Meibang Pharma Unit Buys 35.3 Million Yuan Land For Pesticide and Fertilizer Plant MT
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd.(SHSE:605033) added to Shanghai Stock Exchange Composite Index CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd.(SHSE:605033) added to Shanghai Stock Exchange A Share Index CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day+4.78%
1 week-12.16%
Current month-12.16%
1 month-16.15%
3 months-4.15%
6 months-29.00%
Current year-27.97%
More quotes
1 week
12.09
Extreme 12.09
14.99
1 month
12.09
Extreme 12.09
15.80
Current year
10.30
Extreme 10.3
19.24
1 year
10.30
Extreme 10.3
19.86
3 years
10.30
Extreme 10.3
30.82
5 years
10.30
Extreme 10.3
30.82
10 years
10.30
Extreme 10.3
30.82
More quotes
Managers TitleAgeSince
Chief Executive Officer 31 18-09-09
Director of Finance/CFO 57 18-09-09
Chairman 38 -
Members of the board TitleAgeSince
Chairman 54 18-09-09
Director/Board Member 57 -
Chief Executive Officer 31 18-09-09
More insiders
Date Price Change Volume
24-06-07 12.93 +4.78% 1,639,000
24-06-06 12.34 -6.37% 1,841,200
24-06-05 13.18 -4.56% 1,151,700
24-06-04 13.81 -3.43% 871,500
24-06-03 14.3 -2.85% 842,100

End-of-day quote Shanghai S.E., June 06, 2024

More quotes
Shaanxi Meibang Pharmaceutical Group Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of pesticide preparations. The Company's products mainly include fungicides and pesticides. The fungicides include 80% dimethylmorpholine water dispersible granules, 27% chunleimycin bromonitrile wettable powder, 72% pyrazole ether ester combined water dispersible granules, 22% chunleimycin chlorobromoisocyanuric acid wettable powder, etc. The insecticides include 21% abamectin benzoate fenitrile suspension, 22% thiamethoxam beta cypermethrin suspension, 45% biphenyl hydrazide ethiconazole suspension, 20% fenitrile bifenthrin suspension, etc.
More about the company
  1. Stock Market
  2. Equities
  3. 605033 Stock